GE HealthCare

Health Care Health Care Equipment Chicago, Illinois Last filing Feb 4, 2026 · FY2025

                    Revenue
                    FY2025
                
$20.6B
                    3y CAGR +4.0%
                    
                    P45
                    
                    +4.8%
                    
                    Net income
                    FY2025
                
$2.1B
                    Net margin +10.1%
                    
                    P43
                    
                    +4.6%
                    
                    Total assets
                    FY2025
                
$36.9B
                    ROA +5.6%
                    
                    P48
                    
                    +11.5%
                    
                    Operating cash flow
                    FY2025
                
$2.0B
                    FCF margin +7.3%
                    
                    P22
                    
                    +1.6%

5 yrs · FY2021–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

30 accounts · 5 years

Total assets $36.9B

Total liabilities $26.3B

Shareholders equity $10.4B

Account	2025	2024	2023	2022	2021
Assets
Cash and Cash Equivalents	21.9%	14.7%	12.8%	7.9%	—
Accounts Receivable	19.2%	18.1%	—	—	—
Inventory	10.8%	9.9%	10.0%	11.7%	—
Other Current Assets	8.7%	7.7%	7.1%	7.7%	—
Total Current Assets	60.6%	50.3%	48.1%	45.4%	—
Property,Plant and Equipment	15.0%	13.0%	12.8%	12.6%	—
Goodwill	65.4%	66.8%	66.2%	69.9%	—
Intangible Assets	5.5%	5.5%	6.4%	8.3%	—
Deferred Tax Assets	21.8%	22.7%	22.9%	8.5%	—
Other Noncurrent Assets	10.7%	9.9%	9.6%	5.6%	—
Total Assets	178.9%	168.2%	166.0%	150.1%	—
Liabilities
Accounts Payable	15.8%	15.4%	15.1%	16.1%	—
Accrued Liabilities	8.1%	7.7%	7.8%	—	—
Deferred Revenue	10.2%	9.9%	9.8%	10.3%	—
Current Portion of Long Term Debt	2.5%	7.6%	5.1%	0.1%	—
Other Current Liabilities	7.7%	7.9%	—	—	—
Total Current Liabilities	44.1%	48.6%	45.9%	39.2%	—
Long Term Debt	46.0%	37.9%	43.1%	44.9%	—
Deferred Tax Liabilities	0.9%	0.3%	0.3%	2.0%	—
Other Noncurrent Liabilities	36.4%	37.5%	39.2%	11.7%	—
Total Liabilities	127.5%	124.2%	128.6%	97.9%	—
Equity
Common Stock	0.0%	0.0%	0.0%	0.0%	—
Additional Paid In Capital	32.5%	33.5%	33.2%	0.0%	—
Retained Earnings	25.6%	16.6%	6.8%	0.0%	—
Treasury Stock	1.1%	0.1%	0.0%	—	—
Accumulated Other Comprehensive Income	-6.7%	-7.0%	-3.5%	-10.2%	—
Total Stockholders Equity	50.3%	42.9%	36.5%	51.0%	—
Noncontrolling Interest	0.1%	0.1%	0.1%	0.0%	—
Temporary Equity and Other	1.0%	1.0%	0.8%	1.3%	—
Total Liabilitiesand Equity	178.9%	168.2%	166.0%	150.1%	—

Income Statement

Revenue, expense, and profitability

16 accounts · 5 years

Revenue $20.6B

Operating income $2.8B

Net income $2.1B

Account	2025	2024	2023	2022	2021
IncomeStatement
Revenues Total Revenue	100.0%	100.0%	100.0%	100.0%	100.0%
Other Income Expense Gross Profit	40.0%	41.7%	40.5%	39.1%	40.8%
Expenses Research and Development	6.1%	6.7%	6.2%	5.6%	4.6%
Expenses Selling,General and Administrative	20.5%	21.7%	21.9%	19.8%	20.3%
Expenses Operating Expenses	26.6%	28.4%	28.1%	25.4%	24.9%
Other Income Expense Operating Income	13.4%	13.3%	12.5%	13.8%	15.9%
Other Income Expense Interest Expense	2.1%	2.6%	2.8%	0.4%	0.2%
Other Income Expense Other Income/expense	2.2%	2.3%	2.4%	0.4%	0.7%
Other Income Expense Income Before Tax	13.4%	13.1%	12.1%	13.7%	16.3%
Income Tax Income Tax Expense	3.0%	2.7%	3.8%	3.1%	3.4%
net Income Other Items Below Tax	-0.3%	-0.3%	-1.2%	-0.2%	-0.2%
net Income net Income	10.1%	10.1%	8.0%	10.4%	12.8%
net Income Comprehensive Income	10.1%	6.6%	3.9%	5.9%	11.7%
Earnings Per Share Basic Eps	0.0%	0.0%	0.0%	0.0%	0.0%
Earnings Per Share Diluted Eps	0.0%	0.0%	0.0%	0.0%	0.0%
Earnings Per Share Weighted Average Shares Diluted	2.2%	2.3%	2.3%	2.5%	2.6%

Cash Flow Statement

Operating, investing, and financing flows

23 accounts · 5 years

Operating cash flow $2.0B

Investing cash flow $-1.0B

Financing cash flow $617.0M

Account	2025	2024	2023	2022	2021
CashFlow
Operating Activities net Income	10.4%	10.4%	8.3%	10.7%	13.0%
Operating Activities Depreciation and Amortization	2.8%	2.9%	3.1%	3.5%	3.6%
Operating Activities Stock Based Compensation	0.6%	0.6%	0.6%	0.4%	0.4%
Operating Activities Deferred Income Taxes	0.9%	0.2%	1.4%	-4.6%	-3.5%
Operating Activities Changes In Operating Assets and Liabilities	-0.7%	-0.3%	0.1%	-1.6%	-7.8%
Operating Activities Other Non Cash Items	-4.4%	-3.9%	-2.8%	0.4%	0.1%
Operating Activities net Cash From Operating Activities	9.6%	9.9%	10.7%	11.6%	9.1%
Investing Activities Capital Expenditures	-2.3%	-2.0%	-2.0%	-1.7%	-1.4%
Investing Activities Business Acquisitions	-1.8%	-1.6%	-0.8%	0.0%	-8.4%
Investing Activities Purchases of Investments	-0.6%	-0.2%	-0.2%	-0.3%	—
Investing Activities Other Investing Activities	-0.3%	-0.8%	0.1%	-0.2%	-0.2%
Investing Activities net Cash From Investing Activities	-5.1%	-4.6%	-2.9%	-2.2%	-10.0%
Financing Activities Proceeds From Debt	13.3%	5.1%	10.3%	44.7%	0.0%
Financing Activities Repayment of Debt	-8.6%	-7.2%	-4.4%	-0.0%	-0.1%
Financing Activities Repurchase of Common Stock	-1.0%	0.0%	0.0%	—	—
Financing Activities Dividends Paid	-0.3%	-0.3%	-0.2%	0.0%	0.0%
Financing Activities Proceeds From Stock Issuance	0.2%	0.2%	0.2%	0.0%	—
Financing Activities Tax Withholding On Stock Based Compensation	-0.2%	-0.5%	-0.2%	0.0%	—
Financing Activities Other Financing Activities	-0.4%	-0.2%	-8.1%	-49.2%	-1.5%
Financing Activities net Cash From Financing Activities	3.0%	-2.9%	-2.4%	-4.5%	-1.5%
Cash Reconciliation Effect of Exchange Rate On Cash	0.3%	-0.4%	-0.1%	-0.0%	-0.2%
Cash Reconciliation Other Changes In Cash	0.0%	-0.0%	0.0%	-0.1%	0.0%
Cash Reconciliation net Change In Cash	7.9%	2.0%	5.4%	4.9%	-2.6%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 5 years

Ratio	2025	2024	2023	2022	2021
Profitability
Gross margin	—	—	—	—	—
Operating margin	+13.4%	+13.3%	+12.5%	+13.8%	+15.9%
Net margin	+10.1%	+10.1%	+8.0%	+10.4%	+12.8%
FCF margin	+7.3%	+7.9%	+8.8%	+9.9%	+7.7%
Growth
Revenue CAGR (3y)	+4.0%	+3.8%	—	—	—
Returns
ROE	+20.1%	+23.6%	+22.0%	+20.5%	—
ROA	+5.6%	+6.0%	+4.8%	+7.0%	—
ROIC	+13.5%	+14.4%	+11.9%	+12.1%	—
Liquidity
Current ratio	1.37x	1.04x	1.05x	1.16x	—
Quick ratio	0.93x	0.68x	—	—	—
Leverage
D/E	2.53x	2.89x	3.53x	1.92x	—
Interest coverage	6.28x	5.21x	4.49x	32.75x	69.88x
Efficiency
Asset turnover	0.56x	0.59x	0.60x	0.67x	—
Cash conversion cycle	—	—	—	—	—

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

GE HealthCare

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history